"Anti-Dyskinesia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. Among the most important clinically are those used for the treatment of Parkinson disease (ANTIPARKINSON AGENTS) and those for the tardive dyskinesias.
| Descriptor ID |
D018726
|
| MeSH Number(s) |
D27.505.954.427.090
|
| Concept/Terms |
Anti-Dyskinesia Agents- Anti-Dyskinesia Agents
- Agents, Anti-Dyskinesia
- Anti Dyskinesia Agents
- Movement Disorder Agents
- Agents, Movement Disorder
- Disorder Agents, Movement
|
Below are MeSH descriptors whose meaning is more general than "Anti-Dyskinesia Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Dyskinesia Agents".
This graph shows the total number of publications written about "Anti-Dyskinesia Agents" by people in this website by year, and whether "Anti-Dyskinesia Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Dyskinesia Agents" by people in Profiles.
-
Kelly EA, Koszewski IJ, Jaradeh SS, Merati AL, Blumin JH, Bock JM. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction. Ann Otol Rhinol Laryngol. 2013 Feb; 122(2):100-8.
-
Jankovic J, Esquenazi A, Fehlings D, Freitag F, Lang AM, Naumann M. Evidence-based review of patient-reported outcomes with botulinum toxin type A. Clin Neuropharmacol. 2004 Sep-Oct; 27(5):234-44.
-
Ashkenazi A, Silberstein SD. Botulinum toxin and other new approaches to migraine therapy. Annu Rev Med. 2004; 55:505-18.
-
Fried GW, Fried KM. Spinal cord injury and use of botulinum toxin in reducing spasticity. Phys Med Rehabil Clin N Am. 2003 Nov; 14(4):901-10.